1. Home
  2. RDHL vs MYSZ Comparison

RDHL vs MYSZ Comparison

Compare RDHL & MYSZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • MYSZ
  • Stock Information
  • Founded
  • RDHL 2009
  • MYSZ 1999
  • Country
  • RDHL Israel
  • MYSZ Israel
  • Employees
  • RDHL N/A
  • MYSZ N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • MYSZ Computer Software: Prepackaged Software
  • Sector
  • RDHL Health Care
  • MYSZ Technology
  • Exchange
  • RDHL Nasdaq
  • MYSZ Nasdaq
  • Market Cap
  • RDHL 3.9M
  • MYSZ 3.8M
  • IPO Year
  • RDHL N/A
  • MYSZ N/A
  • Fundamental
  • Price
  • RDHL $1.02
  • MYSZ $0.98
  • Analyst Decision
  • RDHL
  • MYSZ Strong Buy
  • Analyst Count
  • RDHL 0
  • MYSZ 1
  • Target Price
  • RDHL N/A
  • MYSZ $3.00
  • AVG Volume (30 Days)
  • RDHL 1.6M
  • MYSZ 59.3K
  • Earning Date
  • RDHL 09-05-2025
  • MYSZ 11-14-2025
  • Dividend Yield
  • RDHL N/A
  • MYSZ N/A
  • EPS Growth
  • RDHL N/A
  • MYSZ N/A
  • EPS
  • RDHL N/A
  • MYSZ N/A
  • Revenue
  • RDHL $9,550,000.00
  • MYSZ $7,512,000.00
  • Revenue This Year
  • RDHL $381.91
  • MYSZ $29.71
  • Revenue Next Year
  • RDHL N/A
  • MYSZ N/A
  • P/E Ratio
  • RDHL N/A
  • MYSZ N/A
  • Revenue Growth
  • RDHL 157.62
  • MYSZ N/A
  • 52 Week Low
  • RDHL $1.02
  • MYSZ $0.95
  • 52 Week High
  • RDHL $8.75
  • MYSZ $9.40
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 31.69
  • MYSZ 29.06
  • Support Level
  • RDHL $1.02
  • MYSZ $0.95
  • Resistance Level
  • RDHL $1.11
  • MYSZ $1.18
  • Average True Range (ATR)
  • RDHL 0.14
  • MYSZ 0.06
  • MACD
  • RDHL -0.01
  • MYSZ -0.02
  • Stochastic Oscillator
  • RDHL 3.45
  • MYSZ 15.58

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.

About MYSZ My Size Inc.

My Size Inc is a USA-based technology company that focuses on the development of an application that assists the consumer to accurately take the measurements of his or her own body to fit clothing without the need to try them on using a smartphone. The purpose of the company's business is to simplify the process of clothing acquisition through the Internet and to significantly reduce the rate of returns of clothing which were acquired through the internet and which are returned to the stores because of ill-fitting. The company generates its revenue through selling products to customers and licensing cloud-enabled software subscriptions, associated software maintenance, and support.

Share on Social Networks: